Amgen Inc said signed letter intent estimated 75 mln dlr research development limited partnership fund clinical investigation certain pharmaceutical product currently development .
Neither term arrangement product covered partnership disclosed , Amgen said limited partnership unit include warrant purchase Amgen common stock .
Reuter & # 3 ; 